TAVR

marcapasos después de TAVI

Prognosis After Pacemaker Implantation in Alcohol Septal Ablation

One of the main complications of alcohol septal ablation (ASA) is the alteration in the conduction system, which could lead to permanent pacemaker (PPM) implantation. This is mainly due to the relationship between septal perfusion and the conduction system (especially the right bundle branch). The incidence reported in the literature is 7% to 20% of...

TCT 2022

TCT 2022 | BYPASS CTCA

Studies have shown that the use of computed tomography cardiac angiography (CTCA) prior invasive coronary angiography (ICA) in patients with prior cardiac artery bypass graft (CABG) might reduce procedural time and post procedure kidney injury. 1 out of 5 patients with ischemic cardiomyopathy and prior CABG need to be assessed with ICA within 3 years...

SOLACI-SOCIME 2022 - Advances in Structural Interventions

Advances in Structural Intervention – SOLACI-SOCIME 2022

✔️ Advances in Structural Intervention – SOLACI-SOCIME 2022. ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 – Palabras de Bienvenida – Dr. Guering Eid-Lidt (MEX) 01:53 – Neo-commisural alignment and coronary overlap after TAVI – Dr. Luis Nombela Franco (ESP) 19:17 – Heavily calcified aortic annulus and TAVR – Dr. José Mangione (BRA) 36:15 –...

Resultados alentadores en la válvula mitral percutánea en los pacientes complejos

Is the Cause of Mitral Regurgitation Relevant for MitraClip?

Mitral regurgitation (MR) is the most common valvulopathy: it is present in (at least) 7.5% of patients >75 years old. This pathology can be classified as primary or degenerative MR (DMR) and secondary or functional MR (FMR).   FMR can be caused by dilatation of the left atrium (most often due to atrial fibrillation), occurring in...

Opening Ceremony SOLACI-SOCIME 2022

✔️ Opening Ceremony SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 – Welcoming words – Dr. Guering Eid-Lidt (MEX) 01:41 – Fully understanding our TAVR implantation views and techniques – Dr. Ole de Backer (DNK) 21:51 – Transcatheter interventional heart failure therapies – Dr. Juan Granada (USA) 43:17 – The revolution in the...

Structural: Selected Topics in TAVI | SOLACI-SOCIME 2022

✔️ MITRAL VALVE Session ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Content: 00:09 – Welcoming Words – Dr. Jorge Cortés (MEX) 01:16 – TAVR for aortic regurgitation – Dr. Raj Makkar (USA) 18:53 – Reduced leaflet motion: the real clinical impact – Dr. Ole de Backer (DNK) 34:17 – TAVR in bicuspid aortic valve: Clinical evidence...

SOLACI-SOCIME 2022 - TAVI Complex Anatomy

TAVI Complex Anatomy – SOLACI-SOCIME 2022

✔️ TAVI Complex Anatomy ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:11 – Welcoming words – Dr. Jorge Cortés (MEX) 01:05 – TAVR in complex anatomy. Which is the limit? – Dr. John Paul Vavalle (USA) 13:27 – TAVR in bicuspid aortic valve – Dr. John Paul Vavalle (USA) 31:27 – Calcified annulus. TAVR or...

ESC 2022

ESC 2022 | SECURE Trial

This study, presented by Dr. Valentin Fuster, focused on the importance of medical treatment compliance, initially showing data from the FOCUS study where the poor compliance observed in patients after an acute myocardial infarction (AMI) event was improved by creating a polypill (aspirin, simvastatin, and ramipril). Based on this, the SECURE randomized study was conducted...

¿Es frecuente el uso de IVUS para guiar la ATC?

Optimization by IVUS after FFR Guided PCI: Are There Clinical Benefits for Patients?

Percutaneous coronary interventions have improved during the last decade with 15% rate of target vessel failure (TVF) at 5 years according to the latest reports. We are already familiar with the benefits of functional assessment of lesions with FFR and its clinical outcomes.  Additionally, low post PCI FFR values (FFR ≤ 0.83-≤0.91) have been associated...

valve_in_valve-compressor

Surgical Bioprosthesis Deterioration: Is the Valve-in-Valve Technique a Good Option?

The use of surgical bioprostheses has significantly increased, and while they last 15 years or more, in cases where they fail (usually due to stenosis), the decision-making process is challenging. Transcatheter aortic valve replacement (TAVR) is a good alternative for this situation, although information on the subject matter is still scarce. Currently, the only available...

Top